Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HC9 Ventures is a venture capital firm founded in 2021, based in Woodstock, New York. The firm focuses on partnering with early-stage healthcare companies, providing both capital and industry expertise to help them scale and monetize their businesses. With a fund size of $83 million, HC9 Ventures is dedicated to addressing critical needs within the healthcare system through investments in innovative technology and services.
The firm has established a strong foundation by assembling a limited partner base of over 125 healthcare executives, ensuring that portfolio companies benefit from invaluable industry insights and connections. This operator-LP model enhances the growth potential of their investments, allowing startups to navigate the complexities of the healthcare landscape more effectively.
Since its inception, HC9 Ventures has made significant strides in the healthcare investment space, focusing on Seed and Series A stages. Their commitment to improving healthcare delivery and operational efficiency positions them as a key player in the venture capital arena.
HC9 Ventures primarily invests in Seed and Series A stages, concentrating on healthcare technology and services. The firm seeks to support companies that innovate and improve the healthcare landscape, addressing pressing challenges in care delivery and operational efficiency. Their investment strategy emphasizes the potential for significant returns at these early stages, particularly in sectors such as digital health, mental health, and AI-driven solutions.
HC9 Ventures looks for founders who demonstrate a strong understanding of their market and possess the ability to execute their vision effectively. The firm values innovative approaches that enhance access, convenience, and affordability in healthcare delivery. By leveraging their operator-LP network, HC9 Ventures provides strategic value to portfolio companies, facilitating customer validation and potential partnerships.
HC9 Ventures has built a diverse portfolio of 10 companies, each addressing unique challenges within the healthcare sector. Notable portfolio companies include:
Richard Lungen: General Partner with extensive experience in the healthcare industry. He has a background in operational leadership and has been involved in numerous successful healthcare ventures.
Charlie Falcone: General Partner who brings a wealth of knowledge from his previous roles in healthcare management and investment. He focuses on identifying promising healthcare startups.
Hayley Hovious: Head of Network and Community, responsible for building relationships with portfolio companies and facilitating connections within the healthcare sector.
Helen Ciesielski: Principal with expertise in healthcare investments and operational strategy, contributing to the firm's investment decisions.
Bob Clerici: Fund Operations, overseeing the operational aspects of the firm and ensuring efficient fund management.
Michael Kaushansky: Head of Growth & Strategy, focusing on scaling portfolio companies and enhancing their market presence.
To pitch HC9 Ventures, founders should submit their proposals through the firm's website at hc9.vc or via email at support@your-domain.com. A comprehensive pitch deck is essential, detailing the business model, market opportunity, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In October 2025, HC9 Ventures marked its 10th investment with Optura, a company specializing in AI solutions for healthcare leadership. This investment highlights the firm's commitment to supporting innovative healthcare technology.
Earlier in 2025, HC9 Ventures led a $7.6 million Series A investment in Reema Health, focusing on community-based care navigation. Additionally, they participated in a $15 million Series A round for Laguna Health, which utilizes AI for post-discharge care management.
HC9 Ventures continues to publish quarterly updates, with their latest round-up for Q4 2025 showcasing ongoing activities and developments within their portfolio.
What are HC9 Ventures' investment criteria?
HC9 Ventures focuses on early-stage healthcare companies, particularly those in Seed and Series A stages. They prioritize investments in healthcare technology and services that address critical needs in the healthcare system.
How can I apply or pitch to HC9 Ventures?
Founders can pitch HC9 Ventures through their website at hc9.vc or via email at support@your-domain.com. It is recommended to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes HC9 Ventures different from other investors?
HC9 Ventures differentiates itself through its operator-LP model, where every limited partner is a healthcare executive. This structure provides portfolio companies with access to industry insights, customer validation, and potential partnerships, enhancing their growth prospects.
What is the geographic focus of HC9 Ventures?
HC9 Ventures primarily invests in companies based in the United States, concentrating on the healthcare sector.
What is the typical check size for investments?
While specific check sizes are not publicly disclosed, HC9 Ventures typically invests in Seed and Series A rounds, which generally range from hundreds of thousands to several million dollars.
What kind of post-investment involvement can portfolio companies expect?
HC9 Ventures actively engages with its portfolio companies, providing mentorship, strategic guidance, and access to their extensive network of healthcare executives. This support is aimed at helping companies navigate challenges and scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.